• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用合成肽破坏YY1-EZH2相互作用可抑制乳腺癌发展。

Disruption of YY1-EZH2 Interaction Using Synthetic Peptides Inhibits Breast Cancer Development.

作者信息

Yi Cheng, Li Guangyue, Wang Wenmeng, Sun Yixuan, Zhang Yueling, Zhong Chen, Stovall Daniel B, Li Dangdang, Shi Jinming, Sui Guangchao

机构信息

Key Laboratory of Saline-Alkali Vegetation Ecology Restoration, Ministry of Education, College of Life Science, Northeast Forestry University, Harbin 150040, China.

State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.

出版信息

Cancers (Basel). 2021 May 16;13(10):2402. doi: 10.3390/cancers13102402.

DOI:10.3390/cancers13102402
PMID:34065631
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8156467/
Abstract

Enhancer of zeste homolog 2 (EZH2) is a methyltransferase to mediate lysine 27 trimethylation in histone H3 (i.e., H3K27me3) and repress gene expression. In solid tumors, EZH2 promotes oncogenesis and is considered a therapeutic target. As a transcription factor, Yin Yang 1 (YY1) recruits EZH2 through its oncoprotein binding (OPB) domain to establish gene repression. In this study, we mapped the YY1 protein binding (YPB) domain on EZH2 to a region of 27 amino acids. Both YPB and OPB domain synthetic peptides could disrupt YY1EZH2 interaction, markedly reduce breast cancer cell viability, and efficiently inhibit tumor growth in a xenograft mouse model. We analyzed MDA-MB-231 cells treated with YPB, OPB, and control peptides by chromatin immunoprecipitation DNA sequencing (ChIP-seq) using an antibody against H3K27me3. YPB and OPB treatments altered H3K27me3 on 465 and 1137 genes, respectively, compared to the control. Of these genes, 145 overlapped between the two peptides. Among them, PTENP1, the PTEN pseudogene, showed reduced H3K27me3 signal when treated by either YPB or OPB peptide. Consistently, the two peptides enhanced both PTENP1 and PTEN expression with concomitantly reduced AKT activation. Further studies validated PTENP1's contribution to the anticancer activity of YPB and OPB peptides.

摘要

zeste同源物2增强子(EZH2)是一种甲基转移酶,可介导组蛋白H3赖氨酸27三甲基化(即H3K27me3)并抑制基因表达。在实体瘤中,EZH2促进肿瘤发生,被认为是一个治疗靶点。作为一种转录因子,阴阳1(YY1)通过其癌蛋白结合(OPB)结构域招募EZH2以建立基因抑制。在本研究中,我们将EZH2上的YY1蛋白结合(YPB)结构域定位到一个27个氨基酸的区域。YPB和OPB结构域合成肽均可破坏YY1-EZH2相互作用,显著降低乳腺癌细胞活力,并在异种移植小鼠模型中有效抑制肿瘤生长。我们使用抗H3K27me3抗体,通过染色质免疫沉淀DNA测序(ChIP-seq)分析了用YPB、OPB和对照肽处理的MDA-MB-231细胞。与对照相比,YPB和OPB处理分别改变了465个和1137个基因上的H3K27me3。在这些基因中,两种肽之间有145个重叠。其中,PTEN假基因PTENP1在用YPB或OPB肽处理时显示H3K27me3信号降低。一致地,这两种肽增强了PTENP1和PTEN的表达,同时降低了AKT激活。进一步的研究验证了PTENP1对YPB和OPB肽抗癌活性的贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14d/8156467/d35a31b9f877/cancers-13-02402-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14d/8156467/0137f7184223/cancers-13-02402-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14d/8156467/dd4b7654ec17/cancers-13-02402-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14d/8156467/3b2abfe054e4/cancers-13-02402-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14d/8156467/c677eeb2fbff/cancers-13-02402-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14d/8156467/6aa96a9be087/cancers-13-02402-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14d/8156467/c92ff3795ae2/cancers-13-02402-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14d/8156467/1109ac7cdefe/cancers-13-02402-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14d/8156467/d35a31b9f877/cancers-13-02402-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14d/8156467/0137f7184223/cancers-13-02402-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14d/8156467/dd4b7654ec17/cancers-13-02402-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14d/8156467/3b2abfe054e4/cancers-13-02402-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14d/8156467/c677eeb2fbff/cancers-13-02402-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14d/8156467/6aa96a9be087/cancers-13-02402-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14d/8156467/c92ff3795ae2/cancers-13-02402-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14d/8156467/1109ac7cdefe/cancers-13-02402-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14d/8156467/d35a31b9f877/cancers-13-02402-g008.jpg

相似文献

1
Disruption of YY1-EZH2 Interaction Using Synthetic Peptides Inhibits Breast Cancer Development.使用合成肽破坏YY1-EZH2相互作用可抑制乳腺癌发展。
Cancers (Basel). 2021 May 16;13(10):2402. doi: 10.3390/cancers13102402.
2
Characterization of YY1 OPB Peptide for its Anticancer Activity.YY1 OPB 肽的抗癌活性特征。
Curr Cancer Drug Targets. 2019;19(6):504-511. doi: 10.2174/1568009618666181031153151.
3
Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.阴阳1介导的肿瘤抑制性微小RNA的表观遗传沉默激活肝细胞癌中的核因子κB
J Pathol. 2016 Apr;238(5):651-64. doi: 10.1002/path.4688.
4
Yin Yang 1 promotes mTORC2-mediated AKT phosphorylation.阴阳1促进mTORC2介导的AKT磷酸化。
J Mol Cell Biol. 2016 Jun;8(3):232-43. doi: 10.1093/jmcb/mjw002. Epub 2016 Jan 13.
5
YY1 Oligomerization Is Regulated by Its OPB Domain and Competes with Its Regulation of Oncoproteins.YY1寡聚化受其OPB结构域调控,并与其对癌蛋白的调控相互竞争。
Cancers (Basel). 2022 Mar 22;14(7):1611. doi: 10.3390/cancers14071611.
6
EZH2 Methyltransferase Activity Controls Pten Expression and mTOR Signaling during Fear Memory Reconsolidation.EZH2 甲基转移酶活性在恐惧记忆再巩固期间控制着 PTEN 的表达和 mTOR 信号通路。
J Neurosci. 2018 Aug 29;38(35):7635-7648. doi: 10.1523/JNEUROSCI.0538-18.2018. Epub 2018 Jul 20.
7
The EZH2- H3K27me3-DNMT1 complex orchestrates epigenetic silencing of the wwc1 gene, a Hippo/YAP pathway upstream effector, in breast cancer epithelial cells.EZH2-H3K27me3-DNMT1 复合物协调乳腺癌上皮细胞中 wwc1 基因的表观遗传沉默,wwc1 基因是 Hippo/YAP 通路的上游效应因子。
Cell Signal. 2018 Nov;51:243-256. doi: 10.1016/j.cellsig.2018.08.011. Epub 2018 Aug 16.
8
Polycomb recruitment at the Class II transactivator gene.II类反式激活因子基因处的多梳蛋白招募
Mol Immunol. 2015 Oct;67(2 Pt B):482-91. doi: 10.1016/j.molimm.2015.08.003. Epub 2015 Aug 15.
9
The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation.多梳蛋白Ezh2甲基转移酶调节肌肉基因表达和骨骼肌分化。
Genes Dev. 2004 Nov 1;18(21):2627-38. doi: 10.1101/gad.1241904.
10
Dysregulation of histone H3 lysine 27 trimethylation in transforming growth factor-β1-induced gene expression in mesangial cells and diabetic kidney.转化生长因子-β1诱导的系膜细胞和糖尿病肾病中组蛋白 H3 赖氨酸 27 三甲基化的失调
J Biol Chem. 2019 Aug 23;294(34):12695-12707. doi: 10.1074/jbc.RA119.007575. Epub 2019 Jul 2.

引用本文的文献

1
EZH2 suppresses IR-induced ferroptosis by forming a co-repressor complex with HIF-1α to inhibit ACSL4: Targeting EZH2 enhances radiosensitivity in KDM6A-deficient esophageal squamous carcinoma.EZH2通过与HIF-1α形成共抑制复合物来抑制铁死亡诱导因子(IR)诱导的铁死亡,从而抑制ACSL4:靶向EZH2可增强KDM6A缺陷型食管鳞状细胞癌的放射敏感性。
Cell Death Differ. 2025 Feb 7. doi: 10.1038/s41418-025-01451-5.
2
LncRNA PTENP1/miR-21/PTEN Axis Modulates EMT and Drug Resistance in Cancer: Dynamic Boolean Modeling for Cell Fates in DNA Damage Response.LncRNA PTENP1/miR-21/PTEN 轴调控癌症中的 EMT 和耐药性:DNA 损伤反应中细胞命运的动态布尔建模。
Int J Mol Sci. 2024 Jul 29;25(15):8264. doi: 10.3390/ijms25158264.
3

本文引用的文献

1
Post-translational modifications of EZH2 in cancer.癌症中EZH2的翻译后修饰
Cell Biosci. 2020 Dec 11;10(1):143. doi: 10.1186/s13578-020-00505-0.
2
MALAT1-mediated recruitment of the histone methyltransferase EZH2 to the microRNA-22 promoter leads to cardiomyocyte apoptosis in diabetic cardiomyopathy.MALAT1 介导的组蛋白甲基转移酶 EZH2 募集到 microRNA-22 启动子导致糖尿病心肌病中的心肌细胞凋亡。
Sci Total Environ. 2021 Apr 20;766:142191. doi: 10.1016/j.scitotenv.2020.142191. Epub 2020 Sep 4.
3
Overexpressed lncRNA GATA6-AS1 Inhibits LNM and EMT via FZD4 through the Wnt/β-Catenin Signaling Pathway in GC.
Biological Activity of Natural and Synthetic Peptides as Anticancer Agents.
天然和合成肽作为抗癌剂的生物活性。
Int J Mol Sci. 2024 Jul 1;25(13):7264. doi: 10.3390/ijms25137264.
4
Morphological Changes Induced by TKS4 Deficiency Can Be Reversed by EZH2 Inhibition in Colorectal Carcinoma Cells.TKS4缺陷诱导的形态学变化可通过抑制EZH2在结肠癌细胞中逆转。
Biomolecules. 2024 Apr 5;14(4):445. doi: 10.3390/biom14040445.
5
EZH2-Myc Hallmark in Oncovirus/Cytomegalovirus Infections and Cytomegalovirus' Resemblance to Oncoviruses.EZH2-Myc 标志在致癌病毒/巨细胞病毒感染和巨细胞病毒与致癌病毒的相似性。
Cells. 2024 Mar 19;13(6):541. doi: 10.3390/cells13060541.
6
JMJD3 regulate H3K27me3 modification via interacting directly with TET1 to affect spermatogonia self-renewal and proliferation.JMJD3 通过与 TET1 直接相互作用来调节 H3K27me3 修饰,从而影响精原细胞自我更新和增殖。
BMC Genomics. 2024 Feb 29;25(1):225. doi: 10.1186/s12864-024-10120-9.
7
Long non-coding RNAs PTENP1, GNG12-AS1, MAGI2-AS3 and MEG3 as tumor suppressors in breast cancer and their associations with clinicopathological parameters.长链非编码 RNA PTENP1、GNG12-AS1、MAGI2-AS3 和 MEG3 作为乳腺癌的肿瘤抑制因子及其与临床病理参数的相关性。
Cancer Biomark. 2024;40(1):61-78. doi: 10.3233/CBM-230259.
8
Aquatic Peptide: The Potential Anti-Cancer and Anti-Microbial Activity of GE18 Derived from Pathogenic Fungus .水生肽:来源于致病性真菌的 GE18 的潜在抗癌和抗微生物活性。
Molecules. 2023 Sep 21;28(18):6746. doi: 10.3390/molecules28186746.
9
Zinc Ions Modulate YY1 Activity: Relevance in Carcinogenesis.锌离子调节YY1活性:在致癌作用中的相关性。
Cancers (Basel). 2023 Aug 30;15(17):4338. doi: 10.3390/cancers15174338.
10
Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach.用于胰腺癌诊断和治疗的基于噬菌体的肽:替代方法。
Front Microbiol. 2023 Aug 2;14:1231503. doi: 10.3389/fmicb.2023.1231503. eCollection 2023.
过表达的长链非编码RNA GATA6-AS1通过FZD4经由Wnt/β-连环蛋白信号通路抑制胃癌中的淋巴结转移和上皮-间质转化
Mol Ther Nucleic Acids. 2020 Mar 6;19:827-840. doi: 10.1016/j.omtn.2019.09.034. Epub 2019 Nov 22.
4
HERES, a lncRNA that regulates canonical and noncanonical Wnt signaling pathways via interaction with EZH2.HERES 通过与 EZH2 相互作用来调节经典和非经典 Wnt 信号通路。
Proc Natl Acad Sci U S A. 2019 Dec 3;116(49):24620-24629. doi: 10.1073/pnas.1912126116. Epub 2019 Nov 15.
5
HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2.HOXD-AS1 通过招募 EZH2 表观遗传沉默 PDCD4 赋予胃癌顺铂耐药性。
Open Biol. 2019 Sep 27;9(9):190068. doi: 10.1098/rsob.190068. Epub 2019 Sep 25.
6
mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia.突变及其对临床结局的影响:对1604例新诊断急性髓系白血病患者的分析
Haematologica. 2020 May;105(5):e228-e231. doi: 10.3324/haematol.2019.222323. Epub 2019 Aug 14.
7
LncRNA FOXC2 antisense transcript accelerates non-small-cell lung cancer tumorigenesis via silencing p15.长链非编码RNA FOXC2反义转录本通过沉默p15促进非小细胞肺癌的肿瘤发生。
Am J Transl Res. 2019 Jul 15;11(7):4552-4560. eCollection 2019.
8
CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter.CDYL 通过调控 CDKN1C 启动子上的 H3K27 三甲基化促进小细胞肺癌的化疗耐药性。
Theranostics. 2019 Jul 9;9(16):4717-4729. doi: 10.7150/thno.33680. eCollection 2019.
9
PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway.PTENP1/miR-20a/PTEN 轴通过调节 PI3K/AKT 通路来促进乳腺癌的进展。
J Exp Clin Cancer Res. 2019 Jun 13;38(1):256. doi: 10.1186/s13046-019-1260-6.
10
Targeting EZH2 histone methyltransferase activity alleviates experimental intestinal inflammation.靶向 EZH2 组蛋白甲基转移酶活性可缓解实验性肠道炎症。
Nat Commun. 2019 Jun 3;10(1):2427. doi: 10.1038/s41467-019-10176-2.